- 101. 5
- [Maxillary right first premolar ( HL7V3.0 )] (UMLS (HL7) C0227038) tooth 5 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 151. T-Cell Rich/Histiocyte-Rich Large B-Cell Lymphoma
- (UMLS (NCI) C1321547) T-Cell/Histiocyte Rich Lymphoma =Neoplastic Process ;
|
- 102. 5'-tct ccc agc gtg cgc cat
- [A drug that may kill cancer cells by blocking the production of a protein that makes cancer cells live longer. ( NCI )] (UMLS (NCI) C0914297) Oblimersen;
olbimersen =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 152. t-Test
- [A statistical hypothesis test based on a test statistic whose sampling distribution is a t-distribution. The term "t-test" is often used in a narrower sense: it refers to a popular test aimed at testing the hypothesis that the population mean is equal to some value m (see also t-statistic). The most popular t-tests are aimed at testing the following hypotheses: 1. The population mean is as hypothesized (the population variance is not known); 2. The means of two populations are equal (the population variances are not known but equal); 3. The means of two populations are equal (the population variances are not known and not equal); 4. The correlation coefficient for two random variables is zero; 5. The slope of the population regression line is zero. ( NCI )] (UMLS (NCI) C0871472) =Intellectual Product ;
|
- 103. 5,10,15,20-Tetra-(m-hydroxyphenyl)chlorin
- [An anticancer drug that is also used in cancer prevention. It belongs to the family of drugs called photosensitizing agents. ( NCI )] (UMLS (NCI) C0379149) =Organic Chemical; Pharmacologic Substance
| - 153. T-Zone Lymphoma
- (UMLS (NCI) C0334655) =Neoplastic Process
|
- 104. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, Monosodium Salt(6R-(6alpha,7beta(Z)))-
- [The sodium salt form of cefuroxime and a semi-synthetic, broad-spectrum, beta-lactamase resistant, second-generation cephalosporin antibiotic with bactericidal activity. Cefuroxime sodium inhibits bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall. Lack of cross-linking results in a reduction of cell wall stability and leads to cell lysis. ( NCI )] (UMLS (NCI) C0701852) =Organic Chemical; Antibiotic =CEFUROXIME;
Cefuroxime Axetil =Cefuroxime 1.5 MG/ML Injectable Solution;
CEFUROXIME SODIUM 7.5 GM/VIL;
CEFUROXIME SODIUM 30 MG/ML;
CEFUROXIME SODIUM 15 MG/ML;
CEFUROXIME SODIUM 7.5 MG/ML;
CEFUROXIME SODIUM 7.5 GM;
CEFUROXIME SODIUM 750 MG | - 154. T0
- [No evidence of primary tumor, in accordance with TNM classification system guidelines. (from AJCC 6th Ed.) ( NCI )] (UMLS (NCI) C0475371) =Finding
|
- 105. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2,3-dihydro-2-imino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxomonosodium Salt,(6R-(6alpha,7beta(Z)))-
- [The sodium salt form of ceftizoxime and a semi-synthetic, broad-spectrum, beta-lactamase resistant, third-generation cephalosporin antibiotic with bactericidal activity. Ceftizoxime sodium inhibits bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall. Lack of cross-linking results in a reduction of cell wall stability and leads to cell lysis. ( NCI )] (UMLS (NCI) C0282391) =Organic Chemical; Antibiotic ;
=CEFTIZOXIME;
=ceftizoxime 1 gm injectable powder for injection;
ceftizoxime 10 gm injectable powder for injection;
CEFTIZOXIME SODIUM 2 GM/VIL;
CEFTIZOXIME SODIUM 20 MG/ML;
CEFTIZOXIME SODIUM 40 MG/ML;
CEFTIZOXIME SODIUM 1 GM;
CEFTIZOXIME SODIUM 2 GM;
CEFTIZOXIME SODIUM 500 MG | - 155. T01, T03, T05, T07, T09, T11
- (UMLS (HL7) C1549794) =Intellectual Product =Message structure;
|
- 106. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1Z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-,2,2-dimethyl-1-oxopropoxy)methyl Ester,(6R,7R)-
- [A semi-synthetic, broad-spectrum, beta-lactamase resistant, third-generation cephalosporin antibiotic with bactericidal activity. Cefditoren pivoxil is a prodrug that is rapidly hydrolyzed by intestinal esterases during absorption to the microbiologically active cefditoren, an active aminothiazolyl cephalosporin. Cefditoren inactivates penicillin binding proteins (PBPs) thereby interfering with peptidoglycan synthesis and inhibiting bacterial cell wall synthesis. Another consequence of beta-lactam exposure results in the loss of lipoteichoic acids from the cell wall. Lipoteichoic acids inhibit murein hydrolase activity and their absence from the cell wall triggers uncontrolled autolytic activity rendering bacterial cells susceptible to osmotic shock. This results in a reduction of cell wall stability and causes cell lysis. ( NCI )] (UMLS (NCI) C0245519) =Organic Chemical; Antibiotic ;
=CEFDITOREN;
Unclassified Ingredients | - 156. T02, T04, T06, T08, T10
- (UMLS (HL7) C1549795) =Intellectual Product =Message structure;
|
- 107. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, Disodium Salt,(6R-(6alpha,7alpha))-
- [The disodium salt form of cefotetan and a semi-synthetic, broad-spectrum, beta-lactamase-resistant, second-generation cephalosporin antibiotic with bactericidal activity. Cefotetan disodium causes inhibition of bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall. This results in a reduction of cell wall stability and causes cell lysis. ( NCI )] (UMLS (NCI) C0700471) =Organic Chemical; Antibiotic =CEFOTETAN;
=CEFOTETAN DISODIUM 1 GM/VIL;
CEFOTETAN DISODIUM 2 GM/VIL;
CEFOTETAN DISODIUM 1 GM/50ML;
CEFOTETAN DISODIUM 2 GM/50ML;
CEFOTETAN DISODIUM 10 GM/VIL;
CEFOTETAN DISODIUM 2 GM;
CEFOTETAN DISODIUM 1 GM;
| - 157. T1
- (UMLS (NCI) C0475372) =Finding
|
- 108. 6
- [Maxillary right canine ( HL7V3.0 )] (UMLS (HL7) C0227039) tooth 6 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 158. T1 Vertebra
- (UMLS (NCI) C0459933) =Body Part, Organ, or Organ Component ;
|
- 109. 6 thiopurine riboside
- [ ] (UMLS (CSP) C0599534) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 159. T10 Vertebra
- (UMLS (NCI) C0459955) =Body Part, Organ, or Organ Component
|
- 110. 7
- [Maxillary right lateral incisor ( HL7V3.0 )] (UMLS (HL7) C0227040) tooth 7 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 160. T11 Vertebra
- (UMLS (NCI) C0459956) =Body Part, Organ, or Organ Component
|
- 111. 8
- [Maxillary right central incisor ( HL7V3.0 )] (UMLS (HL7) C0227042) tooth 8 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 161. T12
- (UMLS (HL7) C1549876) =Intellectual Product =Message structure;
|
- 112. 9
- [Maxillary left central incisor ( HL7V3.0 )] (UMLS (HL7) C0227043) tooth 9 =Body Part, Organ, or Organ Component =Permanent dentition;
| - 162. T12 Vertebra
- (UMLS (NCI) C0459957) =Body Part, Organ, or Organ Component
|
- 113. C (_cum_)
- (UMLS (HL7) C1548612) =Temporal Concept =Repeat;
| - 163. T138067
- [An anticancer drug that belongs to the family of drugs called mitotic inhibitors. It inhibits the growth of cancer cells by preventing cell division. ( NCI )] (UMLS (NCI) C0767921) =Organic Chemical; Pharmacologic Substance ;
|
- 114. T
- [Mandibular right second primary molar ( HL7V3.0 )] (UMLS (HL7) C0227099) =Body Part, Organ, or Organ Component =Primary dentition;
| - 164. T138067 Sodium
- [A synthetic pentafluorophenylsulfonamide with potential antineoplastic activity. T138067 covalently binds to and selectively modifies the beta 1, beta 2, beta 3, and beta 4 isotypes of beta tubulin at a conserved cysteine residue, resulting in disruption of microtubule polymerization, collapse of the cytoskeleton, an increase in chromosomal ploidy, cell cycle arrest, and tumor cell apoptosis. (NCI04) ( NCI )] (UMLS (NCI) C0678103) =Organic Chemical; Pharmacologic Substance ;
|
- 115. T
- [Used to describe the quotient of a normal random variable and the square root of a c2 random variable. The t-distribution has one parameter n, the number of degrees of freedom. The relationship to mean m and variance s2 are: m = 0 and s2 = n / (n - 2) ( HL7V3.0 )] (UMLS (HL7) C1552647) =Quantitative Concept =ProbabilityDistributionType;
| - 165. T1a
- (UMLS (NCI) C0475383) =Classification
|
- 116. T
- [One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion). ( NCI )] (UMLS (NCI) C0475455) =Classification ;
| - 166. T1b
- (UMLS (NCI) C0475385) =Classification
|
- 117. T 1551
- (UMLS (NCI) C0039184) =Organic Chemical; Antibiotic ;
| - 167. T1c
- (UMLS (NCI) C0475386) =Classification
|
- 118. T antigen
- [Proteins encoded by the genomes of specific DNA tumor viruses that are associated with the neoplastic transformation of infected cells. T-antigens stimulate the production of antibodies and are immunogenic. ( NCI )] (UMLS (CSP) C0003343) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 168. T2
- (UMLS (NCI) C0475373) =Finding
|
- 119. T cadherin
- [ ] (UMLS (CSP) C0390690) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 169. T2 toxin
- [potent mycotoxin produced in feedstuffs by some Fusarium species. ( CSP )] (UMLS (CSP) C0039185) =Organic Chemical; Hazardous or Poisonous Substance ;
=Fungal Toxin;
sesquiterpene |
- 120. T Cell
- [lymphocytes responsible for cell-mediated immunity, formed when lymphocytes circulate through the thymus gland and differentiate to thymocytes; when exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. ( CSP )] (UMLS (NCI) C0039194) =Cell =lymphocyte;
=helper T lymphocyte;
suppressor T lymphocyte;
CTL;
| - 170. T2 Vertebra
- (UMLS (NCI) C0459936) =Body Part, Organ, or Organ Component ;
|
- 121. T Cell Receptor Signaling Pathway
- [The T Cell Receptor plays a key role in the immune system. The specificity of the receptor is governed by the binding site formed from the mature alpha and beta chains or gamma and delta chains in gamma/delta T Cells. It is the ability of this receptor to bind a complex of foreign peptide in the groove of an MHC molecule that leads to T cell activation. Upon activation the T cell can assist in activating other cells or carry out cytolytic attacks depending on the particular T cell type. The CD3 complex and CD4 (Th cells) or CD8 (Tc cells) work to transmit the activation signal to the T cell's transcriptional machinery upon engagement of the receptor. (BioCarta) ( NCI )] (UMLS (NCI) C1325934) =Molecular Function ;
| - 171. T2a
- (UMLS (NCI) C0475387) =Classification
|
- 122. T dynamin
- [A subtype of dynamin found expressed exclusively in the testis, lung and brain. ( MSH )] (UMLS (CSP) C0753288) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 172. T2b
- (UMLS (NCI) C0475388) =Classification
|
- 123. T lymphocyte depletion therapy
- [ ] (UMLS (CSP) C1171367) =Therapeutic or Preventive Procedure ;
| - 173. T2c
- (UMLS (NCI) C0475389) =Classification
|
- 124. T lymphocyte marker
- [ ] (UMLS (CSP) C0598072) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 174. T3
- (UMLS (NCI) C0475374) =Finding
|
- 125. T(1)-T(6) level spinal cord injury, unspecified
- [ ] (UMLS (ICD9CM) C0161427) =Injury or Poisoning
| - 175. T3 Vertebra
- (UMLS (NCI) C0459952) =Body Part, Organ, or Organ Component
|
- 126. T(1)-T(6) level with other specified spinal cord injury
- (UMLS (ICD9CM) C0859378) T1-T6 SPIN CORD INJ NEC =Injury or Poisoning
| - 176. T3a
- (UMLS (NCI) C0475390) =Classification
|
- 127. T(7)-T(12) level spinal cord injury, unspecified
- [ ] (UMLS (ICD9CM) C0161432) =Injury or Poisoning
| - 177. T3b
- (UMLS (NCI) C0475391) =Classification
|
- 128. T(7)-T(12) level with other specified spinal cord injury
- [ ] (UMLS (ICD9CM) C0161436) =Injury or Poisoning
| - 178. T3c
- (UMLS (NCI) C0475394) =Classification
|
- 129. T-1220
- (UMLS (NCI) C0008877) =Organic Chemical; Antibiotic
| - 179. T4
- (UMLS (NCI) C0475751) =Finding
|
- 130. T-Cell Activation
- [T-Cell Activation involves stimulation of T lymphocytes by receptor interaction with mitogens or cell surface-displayed antigens resulting in biosynthesis of lymphokines, cell proliferation, cell differentiation, and maturation to support immune activity. ( NCI )] (UMLS (NCI) C1155065) =Cell Function
| - 180. T4 Vertebra
- (UMLS (NCI) C0459951) =Body Part, Organ, or Organ Component
|
- 131. T-Cell and NK-Cell Neoplasm
- (UMLS (NCI) C1336554) T-Cell Neoplasm =Neoplastic Process ;
| - 181. T4a
- (UMLS (NCI) C0475395) =Classification ;
|
- 132. T-cell depletion
- [Treatment to destroy T cells, which play an important role in the immune response. Elimination of T cells from a bone marrow graft from a donor may reduce the chance of an immune reaction against the recipient's tissues. ( NCI )] (UMLS (NCI) C0677960) =Therapeutic or Preventive Procedure
| - 182. T4b
- (UMLS (NCI) C0475396) =Classification ;
|
- 133. T-Cell Immunodeficiency
- (UMLS (NCI) C1274233) =Disease or Syndrome
| - 183. T4c
- (UMLS (NCI) C0475397) =Classification ;
|
- 134. T-Cell Leukemia Translocation Altered Gene
- [This gene is putatively involved in the regulation of cell growth. ( NCI )] (UMLS (NCI) C1336599) TCTA;
TCTA Gene =Gene or Genome ;
| - 184. T4d
- (UMLS (NCI) C0475398) =Classification ;
|
- 135. T-Cell Leukemia Translocation Altered Gene Product
- [Ubiquitously expressed (highest in kidney) 103-aa 11-kDa T-Cell Leukemia Translocation Altered Gene Product is encoded by human TCTA Gene. (NCI) ( NCI )] (UMLS (NCI) C1336600) TCTA;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 185. T5 Vertebra
- (UMLS (NCI) C0459950) =Body Part, Organ, or Organ Component
|
- 136. T-Cell Leukemia, Homeobox 1 Gene
- [This gene plays a role in transcriptional regulation and organogenesis. Translocations in the gene are associated with acute T-cell leukemia. ( NCI )] (UMLS (NCI) C0920270) TLX1;
TLX1 Gene;
=Gene or Genome | - 186. T6 Vertebra
- (UMLS (NCI) C0459949) =Body Part, Organ, or Organ Component
|
- 137. T-Cell Leukemia/Lymphoma 1B Gene
- [This gene plays a role in the development of B cells. It is also involved in regulation of cell differentiation, growth and survival. ( NCI )] (UMLS (NCI) C1336598) TCL1B;
TCL1B Gene =Gene or Genome ;
| - 187. T7 Vertebra
- (UMLS (NCI) C0459947) =Body Part, Organ, or Organ Component ;
|
- 138. T-Cell Lymphoma Invasion and Metastasis 1 Gene
- [This gene is plays a role in signal transduction, apoptosis and cytoskeletal remodeling. ( NCI )] (UMLS (NCI) C0812248) TIAM1;
TIAM1 Gene =Gene or Genome | - 188. T8 Vertebra
- (UMLS (NCI) C0459953) =Body Part, Organ, or Organ Component
|
- 139. T-Cell Proliferation
- [An increase in the number of all, or specific subsets of, T-cells by cell growth and cell division during an immune response or during development. ( NCI )] (UMLS (NCI) C1155046) =Cell Function
| - 189. T9 Vertebra
- (UMLS (NCI) C0459954) =Body Part, Organ, or Organ Component
|
- 140. T-Cell Proliferation of Uncertain Malignant Potential
- (UMLS (NCI) C1336550) =Neoplastic Process ;
| - 190. T900607
- [A pentafluorophenylsulfonamide compound with potential antineoplastic activity. T900607 inhibits tubulin polymerization by binding irreversibly to colchicine binding sites, resulting in cell cycle arrest and apoptosis. (NCI04) ( NCI )] (UMLS (NCI) C1327873) =Organic Chemical; Pharmacologic Substance
|
- 141. T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant
- (UMLS (NCI) C1336551) T-Cell Prolymphocytic Leukemia, Sezary Cell-like Variant =Neoplastic Process ;
| - 191. Ta element
- [rare metallic element, symbol Ta, atomic number 73; noncorrosive and malleable metal used for plates or disks to replace cranial defects, for wire sutures, and for prosthetic appliances. ( CSP )] (UMLS (CSP) C0039297) =Element, Ion, or Isotope =heavy metal;
|
- 142. T-Cell Prolymphocytic Leukemia, Small Cell Variant
- (UMLS (NCI) C1336552) =Neoplastic Process ;
| - 192. TAB
- [A solid dosage form containing medicinal substances with or without suitable diluents. (NCI) ( NCI )] (UMLS (NCI) C0039225) =Biomedical or Dental Material =PILL;
=Vaginal Tablet;
Disintegrating Tablet;
Sublingual Tablet;
Oral Tablet;
Vaginal Tablet;
Oral Tablet |
- 143. T-Cell Receptor Alpha
- [One component of the alpha-beta T-cell receptor. Encoded by a locus on chromosome 14. Somatic recombination results in formation of the active gene. ( NCI )] (UMLS (NCI) C0087048) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
| - 193. TAB DISP
- [A tablet that prior to administration, is intended to be placed in liquid, where it forms a suspension. This pharmaceutical dosage form formerly was referred to as a Dispersible Tablet. The term Tablet, Dispersible is no longer used for approved drug products. ( NCI )] (UMLS (NCI) C1273630) TAB FOR SUSP;
Tablet For Suspension Dosage Form;
Tablet For Suspension Dose Form;
TABLET, DISPERSIBLE;
TABLET, FOR SUSPENSION =Manufactured Object |
- 144. T-Cell Receptor Beta
- [One component of the alpha-beta T-cell receptor. Encoded by a locus on chromosome 7. Somatic recombination results in formation of the active gene. ( NCI )] (UMLS (NCI) C0087049) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
| - 194. tabernanthine
- [ ] (UMLS (CSP) C0075758) =Organic Chemical; Pharmacologic Substance ;
|
- 145. T-Cell Receptor Delta
- [One component of the gamma-delta T-cell receptor. Encoded by a locus on chromosome 14. Somatic recombination results in formation of the active gene. ( NCI )] (UMLS (NCI) C0087050) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
| - 195. Tabes dorsalis
- [Parenchymatous NEUROSYPHILIS marked by slowly progressive degeneration of the posterior columns, posterior roots, and ganglia of the spinal cord. The condition tends to present 15 to 20 years after the initial infection and is characterized by lightening-like pains in the lower extremities, URINARY INCONTINENCE; ATAXIA; severely impaired position and vibratory sense, abnormal gait (see GAIT DISORDERS, NEUROLOGIC), OPTIC ATROPHY; Argyll-Robertson pupils, hypotonia, hyperreflexia, and trophic joint degeneration (Charcot's Joint; see ARTHROPATHY, NEUROGENIC). (From Adams et al., Principles of Neurology, 6th ed, p726) ( MSH )] (UMLS (ICD9CM) C0039223) =Disease or Syndrome =Neurosyphilis;
myelopathy |
- 146. T-Cell Receptor Gamma
- [One component of the gamma-delta T-cell receptor. Encoded by a locus on chromosome 7. Somatic recombination results in formation of the active gene. ( NCI )] (UMLS (NCI) C0087051) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
| - 196. Table
- [A piece of furniture having a smooth flat top that is usually supported by one or more vertical legs or any object of a similar appearance. ( NCI )] (UMLS (NCI) C0039224) =Manufactured Object
|
- 147. T-Cell Receptor Gene
- [The T-cell antigen receptors consist of a heterodimer of integral membrane glycoproteins. Two distinct receptors exist, alpha/beta and gamma/delta. Alpha/beta receptors are found on helper and cytotoxic T-cells and are specific for antigenic peptides presented in association with MHC gene products. Gamma/delta receptors, found in association with CD3, directly recognize proteins and non-proteinacious phospho-ligands. Alpha/beta and gamma/delta are non-covalently associated with CD3-gamma, -delta, -epsilon, and -zeta proteins, forming the TCR-CD3 complex, which activate MAPKs and JNK1 through the CD3 antigens, the adaptor protein LAT, and tyrosine kinases LCK and ZAP70. The genes for T-cell receptor subunits are encoded by distinct gene elements that are assembled by somatic rearrangement during T-cell development. Translocations and inversions of these loci are observed in human T-cell leukemias and lymphomas. ( NCI )] (UMLS (NCI) C0524889) =Gene or Genome ;
| - 197. Table Bluff Reservation - Wiyot Tribe, California
- (UMLS (HL7) C1554515) =Population Group =NativeEntityContiguous;
|
- 148. T-Cell Receptor Interacting Molecule
- [Expressed in T cells (not B cells or monocytes) of the thymus, spleen, lymph nodes, and peripheral leukocytes by human TRIM Gene, 186-aa 29/30-kD disulfide-linked dimeric type III transmembrane adaptor phosphoprotein T-Cell Receptor Interacting Molecule contains an 8-aa extracellular domain (includes a Cys residue), a 19-aa transmembrane region and an intracellular domain with 4 potential phosphorylation sites likely involved in SH2-mediated interactions with signaling proteins. Associated with CD3E and CD3Z, TRIM modulates the TCR-CD3 complex in T lymphocytes. After T-cell activation, TRIM is tyrosine phosphorylated by Src kinases and associates with PIK3R1. (NCI) ( NCI )] (UMLS (NCI) C0756533) TCRIM;
TCR-Interacting Molecule;
TRIM;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 198. Table Mountain Rancheria of California
- (UMLS (HL7) C1554516) =Population Group =NativeEntityContiguous;
|
- 149. T-Cell Receptor, Alpha-Beta
- [T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognize antigens only when presented in association with major histocompatibility (MHC) molecules. ( MSH )] (UMLS (NCI) C0085247) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
| - 199. Table Rule Style
- [Defines table cell rendering characteristics ( HL7V3.0 )] (UMLS (HL7) C1699823) =Functional Concept ;
=StyleType;
=Left-sided rule;
Right-sided rule;
Top Rule;
Bottom Rule |
- 150. T-Cell Receptor, Gamma-Delta
- [T-cell receptors composed of CD3-associated gamma and delta polypeptide chains and expressed primarily in CD4-/CD8- T-cells. The receptors appear to be preferentially located in epithelial sites and probably play a role in the recognition of bacterial antigens. The T-cell receptor gamma/delta chains are separate and not related to the gamma and delta chains which are subunits of CD3 (see ANTIGENS, CD3). ( MSH )] (UMLS (NCI) C0085246) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
| - 200. Table value not found
- [The value received for a common HL7 or user defined table was not found to match allowable table values. ( HL7V3.0 )] (UMLS (HL7) C1554171) =Idea or Concept =Message error condition codes;
MessageCondition |
home
